title: [Effect of pathogenetic treatment on vasopressin secretion in patients with hypothalamic syndrome].
abstract: Blood vasopressin concentration, hypothalamic response to stress resultant from insulin hypoglycemia and to acute furosemide load were measured in 72 patients with neuro-endocrine-metabolic form of hypothalamic syndrome. Pathogenetic treatment was decided upon by sensitivity to dopaminergic drug parlodel and antiserotonin drug peritol. According to the sensitivity tests the patients received either parlodel (5 mg/day) or peritol (12 mg/day) for 3-6 months. There were also patients on symptomatic treatment aimed at reduction of body weight. Peritol treatment promoted a decline in basal blood level of vasopressin and better response to insulin hypoglycemia and furosemide test. Parlodel treatment normalized vasopressin blood concentration and hypothalamic response to stimulators. Routine symptomatic therapy did not induce differences in vasopressin level compared to active stage of the disease.
authors.forename: V N
authors.initials: VN
authors.lastname: Slavnov
authors.forename: V M
authors.initials: VM
authors.lastname: Rudichenko
authors.forename: V A
authors.initials: VA
authors.lastname: Oleĭnik
mesh_terms: D000293:Adolescent; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use*; D003533:Cyproheptadine / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D006801:Humans; D007027:Hypothalamic Diseases / Q000188:drug therapy* / Q000378:metabolism; D008875:Middle Aged; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*; D013495:Supraoptic Nucleus / Q000187:drug effects / Q000378:metabolism*; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000096:biosynthesis*
chemical_list: D018492:Dopamine Antagonists; D014667:Vasopressins; D003533:Cyproheptadine; D012701:Serotonin; D001971:Bromocriptine; D004298:Dopamine
vernacular_title: Vliianie patogeneticheskogo lecheniia na sekretsiiu vasopressina u bol'nykh s gipotalamicheskim sindromom.